ClinicalTrials.gg
Sign In

Biliary Tract Neoplasms clinical trials

The registry lists 519 studies for Biliary Tract Neoplasms across more than 10 countries. 199 are recruiting or about to start. 314 of them are mainly about Biliary Tract Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Gallbladder Neoplasms: 891 studies, 276 open.

ClinicalTrials.gov finds 1,109 studies for Biliary Tract Neoplasms. How that becomes 519 here

This page counts the studies the registry files under Biliary Tract Neoplasms, and those it files under no condition that list Biliary Tract Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,109Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −364Filed under a narrower condition, counted on its own pageGallbladder Neoplasms 233 · Bile Duct Neoplasms 131
  3. −3List Biliary Tract Neoplasms as a condition, but the registry did not file them under itMost often written as “Advanced Biliary Tract Cancer” (1), “Advanced Biliary Tract Cancer(BTC)” (1), and “Liver and Intrahepatic Biliary Tract Cancer” (1). The registry filed them under other conditions only, most often Neuroendocrine Tumors (1) and Genital Neoplasms, Female (1).
  4. −223Match it another way35 name it in the title, 4 in a keyword, and 184 by a synonym or other text the search reads.
  5. 519The count on this page35 of them list Biliary Tract Neoplasms in their own words; the registry filed them under no condition.

Get an email when these change. Save the Biliary Tract Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
161
Recruiting
140
Not yet recruiting
57
Status unknown
53
Active, not recruiting
44
Terminated
40

Phase

Phase 2
301
Phase 1
115
Phase 3
40
Phase 4
7
Early Phase 1
1

Where

China
175
United States
155
Korea, Republic of
96
Japan
50
Spain
46
France
45

Who runs them

AstraZeneca (18) · Peking Union Medical College Hospital (16) · Kansai Hepatobiliary Oncology Group (10) · Fudan University (10) · Shanghai Zhongshan Hospital (10) · National Health Research Institutes, Taiwan (8) · National Cancer Institute (NCI) (8) · Samsung Medical Center (8)

What is being tested here

Drugs under test in Biliary Tract Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Gemcitabine8445
Lenvatinib7015
Adebrelimab708
Cisplatin6425
Durvalumab4315
Fluorouracil4214
Zanidatamab436
Ivonescimab415
Sacituzumab tirumotecan404
Capecitabine3115

Drug classes tested here Immune checkpoint inhibitors 40 open · Tyrosine kinase inhibitors (TKIs) 19 open · Antimetabolites 16 open · Antibody-drug conjugates (ADCs) 10 open · Antimitotic agents 2 open

Coming up

24phase 3 studies under way
75studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 140 Biliary Tract Neoplasms studies recruiting now, 80 (57%) set no upper age limit and 37 (26%) stop at 75 or younger. 6 (4%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (3%) take healthy volunteers.

Recruiting studies that take each age, of 140
AgeWomenMen
104 (3%)4 (3%)
18130 (93%)130 (93%)
30139 (99%)139 (99%)
40140 (100%)140 (100%)
50140 (100%)140 (100%)
65140 (100%)140 (100%)
75135 (96%)135 (96%)
8591 (65%)91 (65%)

Across all 519 studies, recruiting or not: 18% stop at 75 or younger and <1% at 65; 3% take children; 0% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Biliary Tract Neoplasms studies take

Of 129 phase 2 interventional studies under Biliary Tract Neoplasms, half reached primary completion within 39 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 137 mo30–… · 34 studies——
Phase 1/260 mo33–68 · 48 studies——
Phase 239 mo29–68 · 129 studies—39 mo29–60 · 99 studies
Interventional, no phase35 mo26–63 · 25 studies——
Observational58 mo37–132 · 44 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Results posted3

Stopped2

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 519. Browse all 519 → or search them.